SMARCC1 and breast cancer: However, no significant change in BAF155 R1064 dimethylation, which is another well-known target of CARM1 in breast cancer cells35, was observed, suggesting that dimethylation of BAF155 R1064 might be cell type-dependent (Supplementary Fig. 15a).